干细胞
Post-PCI Selection of Antithrombotic Therapy
Post-PCI Selection of Antithrombotic Therapy Improvements in antithrombotic pharmacotherapy have led to important reductions in complications after percutaneous coronary intervention. By John P. Vavalle, 医学博士, and Robert A. Harrington, MD Since the introduction of percutaneous coronary intervention (PCI) 多于 3 decades ago, the rates of procedural success and associated 阅读更多…
